SIMONOVIĆ BABIĆ, J. et al. Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ /ritonavir + dasabuvir + ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia. Vojnosanitetski pregled, v. 76, n. 5, 11 Feb.2021.